Patrick G. Lepore, Director at VYNE Therapeutics Inc. (VYNE), bought 13,000 shares at $3.91 ($51K) on 2023-11-15, disclosed to the SEC on 2023-11-17.
Open-market purchase of $51k VYNE by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| LCI | BUY | 2022-11-14 | $49K | — | Filing → |
| LCI | BUY | 2022-05-17 | $27K | — | Filing → |
| LCI | BUY | 2022-02-10 | $44K | — | Filing → |